MCGRATH YVONNE (VP, Research and Development) sold 7.93K shares of ITEOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $195.7K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/19/2021ACC: 0000899243-21-019921
Officer· VP, Research and Development
Since Jul 2020
-7.93K
Net shares
Net seller
$195.7K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
7.93K acquired · 15.85K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+7.93K
Price / share
$4.23
Trade value
$33.53K
% of position
New position
5/17/2021
0.00→7.93K
Common Stock
Direct
Shares
−5.81K
Price / share
$24.41
Trade value
$141.78K
% of position
73.3%
5/17/2021
7.93K→2.12K
Common Stock
Direct
Shares
−2.03K
Price / share
$25.43
Trade value
$51.60K
% of position
95.8%
5/17/2021
2.12K→90.00
Common Stock
Direct
Shares
−90.00
Price / share
$26.01
Trade value
$2.34K
% of position
New position
5/17/2021
90.00→0.00
Total
Net shares
+0.00
Net value
-$162.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/17/2021 | M · Option Exercise | +7.93K | $4.23 | $33.53K | New position | 0.00 | 7.93K |
| Common Stock Direct | 5/17/2021 | S · Sale | −5.81K | $24.41 | $141.78K | 73.3% | 7.93K | 2.12K |
| Common Stock Direct | 5/17/2021 | S · Sale | −2.03K | $25.43 | $51.60K | 95.8% | 2.12K | 90.00 |
| Common Stock Direct | 5/17/2021 | S · Sale | −90.00 | $26.01 | $2.34K | New position | 90.00 | 0.00 |
| Total | +0.00 | -$162.19K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
7.93K shares
Shares
−7.93K
Strike price
4.23
Held after
118.90K
Exercisable
—
5/17/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock7.93K shares | 5/17/2021 | M · Option Exercise | −7.93K | 4.23 | — | 118.90K |